secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-05-22T21:05:53+00:00
Accession:  0001193125-26-237150
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Three directors resign from Tempest Therapeutics board effective May 22, 2026
-----------------------------------------------------------------------------

- Stephen Brady, Michael Raab, and Christine Pellizzari resigned from the Tempest board on May 22, 2026.
- Resignations not due to any disagreement with the company on operations, policies, or practices.
- Separation agreements waive accrued unpaid director retainer fees; stock options and indemnification remain.
- Board size reduced by three members; no replacements announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/0001193125-26-237150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/d29824d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-237150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer